6C3-17898-78604 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-16
Registered in v-safe
2021-01-16
Dose 1 — Pfizer-BioNTech
2021-01-16
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness, Abdominal pain

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-19
Survey response — days 1–6 daily, dose 1
MedDRA: Sinus disorder — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Sinus issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-22
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Swelling, Itching · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-22
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-24
Survey response — day 7, dose 1
MedDRA: Hypersensitivity — Feeling: Poor · Site: Swelling, Itching · Be unable to do your normal daily activities

Free text: Allergic reaction avoided all usual triggers

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-24
Report sent to call center — day 7, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-02-19
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-16	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-19	Successful	Participant prefers to complete VAERS report online
2021-01-22	Successful	Participant prefers to complete VAERS report online
2021-01-24	Successful 2021-02-19	Participant prefers to complete VAERS report online

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-19

Systemic reaction (other): Sinus issues

Release 2 — day 7, dose 1

2021-01-24

Systemic reaction (other): Allergic reaction avoided all usual triggers

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Hypersensitivity	✓	✓	✓
SRO	Sinus disorder	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release